Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 20 Mar 2007):
Free Full Text!
See links below

Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane.

Full Abstract

G protein-coupled receptor 30 (GPR30), a seven-transmembrane receptor (7TMR), is associated with rapid estrogen-dependent, G protein signaling and specific estrogen binding. At present, the subcellular site of GPR30 action is unclear. Previous studies using antibodies and fluorochrome-labeled estradiol (E2) have failed to detect GPR30 on the cell surface, suggesting that GPR30 may function uniquely among 7TMRs as an intracellular receptor. Here, we show that detectable expression of GPR30 on the surface of transfected HEK-293 cells can be selected by fluorescence-activated cell sorting. Expression of GPR30 on the cell surface was confirmed by confocal microscopy using the lectin concanavalin A as a plasma membrane marker. Stimulation of GPR30-expressing HEK-293 cells with 17beta-E2 caused sequestration of GPR30 from the cell surface and resulted in its codistribution with clathrin and mobilization of intracellular calcium stores. Evidence that GPR30 signals from the cell surface was obtained from experiments demonstrating that the cell-impermeable E2-protein conjugates E2-BSA and E2-horseradish peroxidase promote GPR30-dependent elevation of intracellular cAMP concentrations. Subcellular fractionation studies further support the plasma membrane as a site of GPR30 action with specific [3H]17beta-E2 binding and G protein activation associated with plasma membrane but not microsomal, or other fractions, prepared from HEK-293 or SKBR3 breast cancer cells. These results suggest that GPR30, like other 7TMRs, functions as a plasma membrane receptor.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Filardo, E (E); Quinn, J (J); Pang, Y (Y); Graeber, C (C); Shaw, S (S); Dong, J (J); Thomas, P (P);

Affiliation: Department of Medicine, Brown University, and Rhode Island Hospital, 593 Eddy Street, Aldrich Building, Room 718, Providence, Rhode Island 02903, USA. edward_filardo(-atsign-)brown.edu

Grants: RR P20 RR017695 (Agency:NCRR NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Journal: Endocrinology (Endocrinology), published in United States. (Language: eng)

Reference: 2007-Jul; vol 148 (issue 7) : pp 3236-45

Dates: Created 2007/06/18; Completed 2007/10/02; Revised 2007/12/03;

PMID: 17379646, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Clathrin (0) ; Estrogens (0) ; GPER protein, human (0) ; Receptors, Estrogen (0) ; Receptors, G-Protein-Coupled (0) ; Recombinant Fusion Proteins (0) ; Concanavalin A (11028-71-0) ; Estradiol (50-28-2) ; Calcium (7440-70-2)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

3/4/2008
6/2/2008
Higher Relevance Score (20)
Lower Relevance Score (11)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index